Mitsui exits India's Arch for a song?
This article was originally published in Scrip
Executive Summary
The Japanese trading to investment to services conglomerate, Mitsui & Co, has confirmed exiting Arch Pharmalabs – a divestment that comes less than two years since it substantially raised its holding in the Indian intermediates and active pharmaceutical ingredients (API) contract manufacturing firm.